DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association study
International SSc Group: P. Carreira, I. Castellvi, R. Ríos, N. Ortego-Centeno, R. García Portales, A. Fernández-Nebro, F.J. García-Hernández, M.A. Aguirre, B. Fernández-Gutiérrez, L. Rodríguez-Rodríguez, P. García de la Peña, E. Vicente, J.L. Andreu, M. Fernández de Castro, F.J. López-Longo, V. Fonollosa, A. Guillén, G. Espinosa, C. Tolosa, A. Pros, E. Beltrán, M. Rodríguez Carballeira, F.J. Narváez, M. Rubio Rivas, V. Ortiz-Santamaría, A.B. Madroñero, M.A. González-Gay, B. Díaz, L. Trapiella, M.V. Egurbide, P. Fanlo-Mateo, L. Saez-Comet, F. Díaz, J.A. Roman-Ivorra, J.J. Alegre Sancho, M. Freire, F.J. Blanco Garcia, N. Oreiro, T. Witte, A. Kreuter, G. Riemekasten, P. Airo, C. Magro, A.E. Voskuyl, M.C. Vonk, R. Hesselstrand, A. Nordin, C. Lunardi, G. Moroncini, A. Gabrielli, A. Hoffmann-Vold, J.H.W. Distler, L. Padyukov, B.P.C. Koeleman, T.R.D.J. Radstake, G. Orozco, A. Barton, C. Fonseca, The PRECISESADS Clinical Consortium: Barbara Vigone, Jacques-Olivier Pers, Alain Saraux, Valérie Devauchelle-Pensec, Divi Cornec, Sandrine Jousse-Joulin, Bernard Lauwerys, Julie Ducreux, Anne-Lise Maudoux, Carlos Vasconcelos, Ana Tavares, Esmeralda Neves, Raquel Faria, Mariana Brandão, Ana Campar, António Marinho, Fátima Farinha, Miguel Angel Gonzalez-Gay Mantecón, Ricardo Blanco Alonso, Alfonso Corrales Martínez, Ricard Cervera, Ignasi Rodríguez-Pintó, Gerard Espinosa, Rik Lories, Ellen De Langhe, Nicolas Hunzelmann, Doreen Belz, Torsten Witte, Niklas Baerlecken, Georg Stummvoll, Michael Zauner, Michaela Lehner, Eduardo Collantes, Rafaela Ortega-Castro, M Angeles Aguirre-Zamorano, Alejandro Escudero-Contreras, M Carmen Castro-Villegas, Norberto Ortego, María Concepción Fernández Roldán, Enrique Raya, Inmaculada Jiménez Moleón, Enrique de Ramon, Isabel Díaz Quintero, Pier Luigi Meroni, Maria Gerosa, Tommaso Schioppo, Carolina Artusi, Carlo Chizzolini, Aleksandra Zuber, Donatienne Wynar, Laszló Kovács, Attila Balog, Magdolna Deák, Márta Bocskai, Sonja Dulic, Gabriella Kádár, Falk Hiepe, Velia Gerl, Silvia Thiel, Manuel Rodriguez Maresca, Antonio López-Berrio, Rocío Aguilar-Quesada, Héctor Navarro-Linares, Australian Scleroderma Interest Group: A. Apostolopoulos, N. Ferdowsi, D. Hansen, L.V. Host, G. Major, G.-S. Ngian, A. Quinlivan, L. Ross, J. Sahhar, W. Stevens, M. Tabesh, J. Walker, [Background] Systemic sclerosis is an immune-mediated inflammatory disease with marked sex differences in prevalence and severity. Although genome-wide association studies (GWAS) have advanced the understanding of systemic sclerosis genetics, sex-aware approaches remain scarce. We aimed to address this gap by examining autosomal sex-specific genetic factors in systemic sclerosis., [Methods] Based on a chromosomal definition of sex, we conducted a sex-stratified autosomal meta-analysis of GWAS in systemic sclerosis. We retrieved patient-level and control data from a previous GWAS for systemic sclerosis and newly recruited participants from an international multicentre collaboration (data cutoff June 1, 2024). Adult patients (aged ≥18 years) were required to meet the 2013 American College of Rheumatology–European League Against Rheumatism classification criteria or the criteria for early systemic sclerosis proposed by LeRoy and Medsger, 2001. Patients with systemic sclerosis were compared with healthy controls through sex-stratified analyses. Sex-specific loci were functionally annotated and a sex-differential expression analysis was performed to validate the findings. Additionally, we performed a drug repurposing analysis to explore the clinical implications of our findings. People with lived experience of systemic sclerosis were not involved in the study design or conduct., [Findings] After quality control filtering, we included 10 653 patients with systemic sclerosis (1556 male and 9097 female) and 18 043 controls (6990 male and 11 053 female). We identified eight sex-specific loci associated with systemic sclerosis: one novel male-specific locus (BCL11A odds ratio [OR] 1·32 [95% CI 1·20–1·45], p=8·39 × 10–9), two novel female-specific loci (IRF4 OR 0·78 [0·71–0·85], p=2·36 × 10–8 RPL3-PDGFB OR 1·19 [1·12–1·26], p=3·18 × 10–8), and five previously known loci now characterised as female-specific. Functional analyses implicated 39 candidate genes, of which five (IL12RB2, ARHGAP31, UBL7, CSK, and MPI) showed sex-differential expression in patients with systemic sclerosis. Two approved drugs, fostamatinib and dasatinib, were identified as potential repurposing candidates for systemic sclerosis sex-aware treatment., [Interpretation] We report the first evidence of sex-specific genetic architecture in systemic sclerosis. These findings offer insight into the molecular basis of sex differences in the disease, highlighting both IL12RB2 gene and interferon signalling. These results also support the development of sex-aware precision medicine approaches., This work was supported by the Instituto de Salud Carlos III (CP21/00132, PI22/00092 [co-financed by the EU], and Redes de Investigación Cooperativa Orientadas a Resultados en Salud [RD21/0002/0039 and RD24/0007/0016]) and the Innovative Medicines Initiative Joint Undertaking (grant 115565; PRECISESADS project; these resources comprise financial contribution from the EU's Seventh Framework Program [FP7/2007–2013] and European Federation of Pharmaceutical Industries and Associations companies' in-kind contribution). IR-M (FPU21/02746) and CR-B (FPU22/01652) were supported by the programme Formación de Profesorado Universitario funded by the Spanish Ministry of Science, Innovation, and Universities (MICIU). CR-P was supported by grant PREP2022-000747 funded by MICIU/AEI/10.13039/501100011033 and by the European Social Fund Plus (ESF+). GB-Y's contract is part of the grant PREP2022-000712 funded by MICIU/AEI/10.13039/501100011033 and by ESF+. LO-F is a recipient of a Ramon y Cajal fellowship (RYC2022-036635-I) funded by MICIU/AEI/10.13039/501100011033 and by ESF+. The research was also supported by the UK National Institute for Health and Care Research (NIHR)Manchester Clinical Research Facility (NIHR203956). The views expressed are our own and not necessarily those of the NIHR or the UK Department of Health and Social Care. We thank Sofia Vargas and Gema Robledo for their exceptional technical expertise. We also thank all of the participants who provided the data for their essential collaboration and all members of the PRECISESADS consortium. During the preparation of this work we used ChatGPT (GPT 4) to enhance the writing of some sections of the manuscript. After using this tool, we reviewed and edited the content as needed and take full responsibility for the content of the published article. This research is part of the doctoral degree awarded to IR-M within the Biomedicine programme from the University of Granada., Instituto de Salud Carlos III, EU's Seventh Framework Program, and European Federation of Pharmaceutical Industries and Associations companies., Peer reviewed
Project:
ISCIII / Plan Estatal de Investigación Científica PI22-00092
,
EC / Técnica y de Innovación 2021-2023 115565
,
AEI / FP7 RYC2022-036635-I
DOI: http://hdl.handle.net/10261/438605, https://api.elsevier.com/content/abstract/scopus_id/105040576912
HANDLE: http://hdl.handle.net/10261/438605, https://api.elsevier.com/content/abstract/scopus_id/105040576912